Troax Group (TROAX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
21 Apr, 2026Executive summary
Record order intake in Q1 2026, up 18% year-over-year to EUR 82 million, mainly driven by acquisitions, while organic order intake declined 5% due to weak demand in key segments and regions.
Net sales increased by 5% to EUR 71.8 million, with acquisitions contributing 20% to net sales, but organic sales fell 13–14% due to ramp-up issues and lower volumes.
Profitability was impacted by low volumes and restructuring, with adjusted EBITA margin dropping to 10.1% from 14.0% and EPS at EUR 0.07, down from EUR 0.10.
Market conditions remain soft but showed sequential improvement, especially in warehousing and North America.
Integration of recent acquisitions, including Vichnet, and ongoing transformation in North America and Europe are expected to improve profitability in H2 2026.
Financial highlights
Adjusted EBITA was EUR 7.2 million, down from EUR 9.5 million year-over-year, with margin at 10.1%.
Gross margin remained stable year-over-year at 37.2% and improved sequentially from Q4.
Operating/free cash flow was EUR 4.5 million, reflecting seasonal weakness and higher working capital needs.
Net debt/EBITDA increased to 2.7x, above the long-term target of 2.5, mainly due to acquisitions and lower rolling EBITDA.
Investments totaled EUR 37.6 million, mainly for acquisitions and US machinery.
Outlook and guidance
Management expects improved profitability in H2 2026 as integration and transformation projects are completed.
Market conditions remain uncertain, but demand is showing signs of recovery, especially in warehousing and North America.
Backlog in the U.S. expected to be delivered mainly in Q2, with some spillover into Q3.
Strategy for profitable growth remains unchanged, focusing on leveraging acquisitions and operational efficiency.
Long-term target of EBITA margin above 20% maintained.
Latest events from Troax Group
- Sales and profit fell due to weak demand and restructuring, but acquisitions support 2026 recovery.TROAX
Q4 202519 Apr 2026 - Order intake and sales rose, but margin and profit declined amid market headwinds.TROAX
Q2 20241 Feb 2026 - Sales up 12% and EBITA margin 19.7%, with strong cash flow and global strategic investments.TROAX
Q3 202418 Jan 2026 - APAC surged 94% while Europe declined, but low debt supports future growth and investments.TROAX
Q1 202523 Dec 2025 - Q4 2024 order intake up 12%, EBITA margin 17.2%, strong cash flow, and stable dividend.TROAX
Q4 202423 Dec 2025 - Doubling sales to €550m by 2030, targeting 20% EBITA margin through regional growth and M&A.TROAX
CMD 202520 Nov 2025 - Order intake and sales declined, but cost savings and a strong balance sheet support future growth.TROAX
Q2 202518 Nov 2025 - Order intake and sales fell 7% YoY, but APAC growth and new targets support future optimism.TROAX
Q3 202530 Oct 2025